Back to top
more

Teladoc Health (TDOC)

(Real Time Quote from BATS)

$26.44 USD

26.44
2,637,711

+0.02 (0.08%)

Updated Sep 27, 2022 02:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.63%
2Buy18.00%
3Hold9.55%
4Sell5.25%
5Strong Sell2.32%
S&P50010.82%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (161 out of 251)

Industry: Medical Services

Trades from $1

Balance Sheet

Research for TDOC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Teladoc Health, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Assets          
Cash & Equivalents 896 787 517 479 122
Receivables 169 169 57 44 27
Notes Receivable 0 0 0 0 0
Inventories 73 57 0 0 0
Other Current Assets 87 47 14 11 7
Total Current Assets 1,225 1,060 588 533 156
Net Property & Equipment 27 29 10 10 9
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 16,414 16,602 972 985 658
Deposits & Other Assets 21 18 7 1 1
Total Assets 17,735 17,755 1,603 1,529 824
Liabilities & Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Notes Payable 0 0 0 0 0
Accounts Payable 47 46 9 8 4
Current Portion Long-Term Debt 0 43 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 195 178 81 55 36
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 89 66 0 0 0
Total Current Liabilities 331 333 90 62 40
Mortgages 0 0 0 0 0
Deferred Taxes/Income 80 105 22 32 13
Convertible Debt 1,226 1,380 440 415 207
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 11 12 12 6 5
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,689 1,871 589 516 265
Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 17,473 16,858 1,539 1,435 866
Retained Earnings -1,421 -993 -508 -409 -312
Other Equity -6 19 -17 -13 4
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 16,046 15,884 1,014 1,013 559
Total Liabilities & Shareholder's Equity 17,735 17,755 1,603 1,529 824
Total Common Equity 16,046 15,884 1,014 1,013 559
Shares Outstanding 160.00 144.90 72.30 70.10 57.00
Book Value Per Share 100.29 109.62 14.03 14.45 9.81

Fiscal Year End for Teladoc Health, Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Assets          
Cash & Equivalents 884 839 896 826 786
Receivables 205 192 169 178 179
Notes Receivable 0 0 0 0 0
Inventories 60 71 73 57 57
Other Current Assets 108 107 87 96 82
Total Current Assets 1,257 1,208 1,225 1,157 1,105
Net Property & Equipment 27 28 27 27 28
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 6,730 9,784 16,414 16,402 16,418
Deposits & Other Assets 38 27 21 18 18
Total Assets 8,103 11,092 17,735 17,653 17,611
Liabilities & Shareholders Equity 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Notes Payable 0 0 0 0 0
Accounts Payable 94 47 47 35 42
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 179 163 195 182 151
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 98 97 89 85 83
Total Current Liabilities 371 307 331 302 276
Mortgages 0 0 0 0 0
Deferred Taxes/Income 59 60 80 98 85
Convertible Debt 1,534 1,533 1,226 1,211 1,201
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 9 11 11 11
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 2,018 1,950 1,689 1,665 1,610
Shareholders Equity 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 17,239 17,177 17,473 17,399 17,315
Retained Earnings -11,125 -8,023 -1,421 -1,410 -1,326
Other Equity -30 -11 -6 -1 12
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 6,085 9,143 16,046 15,988 16,001
Total Liabilities & Shareholder's Equity 8,103 11,092 17,735 17,653 17,611
Total Common Equity 6,085 9,143 16,046 15,988 16,001
Shares Outstanding 161.10 161.10 160.00 160.00 159.20
Book Value Per Share 37.77 56.75 100.29 99.92 100.51